Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dermatofibrosarcoma Protuberans.

Aubrey Allen1, Christine Ahn2, Omar P Sangüeza2

  • 1Brody School of Medicine, East Carolina University, 517 Moye Boulevard, Greenville, NC 27834, USA.

Dermatologic Clinics
|August 31, 2019
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: Navigating the Complexity of Dual Clonality in Cutaneous Lymphoma: Challenge.

The American Journal of dermatopathology·2026
Same author

Utility of p16, p21, and PRAME Immunohistochemistry in Melanocytic Lesions.

The American Journal of dermatopathology·2026
Same author

Erratum: Cutaneous Involvement by Diffuse Large B-Cell Lymphoma With Dual B-Cell and T-Cell Clonality and Heavy Admixed T-Cell Infiltrate: Answer.

The American Journal of dermatopathology·2026
Same author

Tumor-to-Tumor Metastasis of Merkel Cell Carcinoma to Warthin Tumor.

International journal of surgical pathology·2026
Same author

Squamous Cell Carcinoma Arising in a Lobomycosis Ulcer: A Rare Presentation.

The American Journal of dermatopathology·2026
Same author

Mohs Micrographic Surgery for Penile Squamous Cell Carcinoma: A Systematic Review.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Dermatofibrosarcoma protuberans (DFSP) is a rare skin cancer with high recurrence but low metastasis risk. Surgical resection is standard, with radiation and targeted therapies like imatinib effective for difficult cases.

Area of Science:

  • Oncology
  • Dermatology
  • Surgical Pathology

Background:

  • Dermatofibrosarcoma protuberans (DFSP) is a rare, locally aggressive skin neoplasm.
  • DFSP is characterized by infiltrative growth and a high rate of local recurrence.
  • Metastasis from DFSP is uncommon, but local control remains a clinical challenge.

Purpose of the Study:

  • To review the characteristics and management of dermatofibrosarcoma protuberans.
  • To highlight the importance of achieving negative surgical margins in DFSP treatment.
  • To discuss alternative and adjuvant therapies for unresectable or recurrent DFSP.

Main Methods:

  • Histopathological review of DFSP morphology, including the characteristic storiform pattern.
  • Analysis of treatment outcomes for surgical resection, radiation therapy, and systemic agents.
Keywords:
Cutaneous soft tissue sarcomaDermatofibrosarcoma protuberansFibrosarcomatous transformationImatinib mesylatet(17;22) translocation

Related Experiment Videos

  • Evaluation of tyrosine kinase inhibitors in the context of DFSP management.

    • Main Results:

    • Surgical resection with clear margins is the primary curative approach for DFSP.
    • Incomplete resection necessitates adjuvant therapies to prevent recurrence.
    • Systemic therapies, including imatinib mesylate, demonstrate efficacy in advanced or unresectable DFSP.

    Conclusions:

    • Effective management of DFSP relies on achieving complete surgical excision.
    • Multimodality treatment strategies are crucial for optimizing outcomes in challenging DFSP cases.
    • Targeted therapies offer a valuable option for patients with unresectable or recurrent dermatofibrosarcoma protuberans.